Testing
FP HER2 GA
The FDA recently approved trastuzumab (Herceptin, Genentech) for use in combination with cisplatin and capecitabine or 5-fluorouracil to treat patients with human epidermal growth factor receptor 2 (HER2)-over expressing (also… HER2/neu gastric cancer, paraffin
Learn more
To be used adjunctively, with an FDA approved HPV high risk test, in patients with either a HPV HR+ ASC-US result or, in women 30 years of age and older,…
Learn more
Learn more
Her2/neu, also known as erbB2 or HER2, plays a key role in the regulation of cell growth. HER2 is over expressed through gene amplification in 25-30% of breast cancer patients.…
Learn more
Learn more
Used to screen women with ASC-US cervical cytology results to determine the need for referral to colposcopy. To be used adjunctively with cervical cytology to screen women 30 years of…
Learn more
Learn more
Intended for use to assist in the confirmation of a diagnosis of a HSV-1 and/or HSV-2 infection.
Learn more
Learn more
Intended for use to assist in the confirmation of a diagnosis of a HSV-1 and/or HSV-2 infection.
Learn more
Learn more
Intended for use to assist in the confirmation of a diagnosis of a HSV-1 and/or HSV-2 infection.
Learn more
Learn more
